Table 3.

A comparison between patients with atherosclerotic vascular events due to atherosclerosis with all other patients

At Enrolment	Patients with AVE	All other Patients*	P value
No. of patients	22	615
Caucasian	17 (77.3%)	328 (53.3%)	0.03
Male	9 (40.9%)	72 (11.7%)	<0.0001
Age at Diagnosis	54.6 ± 13.1	34.6 ± 13.7	< 0.0001
Hypertension	14 (73.6%)	197 (32.3%)	0.002
Obese (BMI >27 F >25 M)	12 (57.1%)	163 (28.1%)	0.004
Smoker (Current or Ex)	14 (63.6%)	225 (36.6%)	0.01
Family History CAD (adjusted for age) **	9 (42.9%)	117 (20.0%)	0.02
Hypercholesterolemia	12 (54.6%)	228 (37.4%)	0.10
Diabetes mellitus	2 (10.5%)	14 (2.4%)	0.08
Corticosteroids	17 (77.3%)	417 (68.5%)	0.38
Antimalarials	16 (72.7%)	386 (63.5%)	0.38
Immunosuppressive drug use	6 (27.3%)	227 (37.3%)	0.34
SLEDAI-2K at presentation	3.32 ± 3.09	5.53 ± 5.63	0.11
AMS at Year 2	3.02 ± 3.11	4.15 ± 3.78	0.12

^*Followed for at least 2 years, AMS=adjusted mean SLEDAI-2K

^**first degree relative Female < 65 years old or Male < 55 years old